Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Species differences in N-glucuronidation.

Chiu SH, Huskey SW.

Drug Metab Dispos. 1998 Sep;26(9):838-47. Review.

2.
3.
4.

N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases.

Kaivosaari S, Finel M, Koskinen M.

Xenobiotica. 2011 Aug;41(8):652-69. doi: 10.3109/00498254.2011.563327. Epub 2011 Mar 24. Review.

PMID:
21434773
5.

Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions.

Ritter JK.

Chem Biol Interact. 2000 Dec 1;129(1-2):171-93. Review.

PMID:
11154740
6.

Reaction of primary and secondary amines to form carbamic acid glucuronides.

Schaefer WH.

Curr Drug Metab. 2006 Dec;7(8):873-81. Review.

PMID:
17168688
7.

Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

EFSA GMO Panel Working Group on Animal Feeding Trials.

Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Review.

PMID:
18328408
8.

N-glucuronidation of benzidine and its metabolites. Role in bladder cancer.

Zenser TV, Lakshmi VM, Davis BB.

Drug Metab Dispos. 1998 Sep;26(9):856-9. Review.

10.

Metabolism of N-acetylbenzidine and initiation of bladder cancer.

Zenser TV, Lakshmi VM, Hsu FF, Davis BB.

Mutat Res. 2002 Sep 30;506-507:29-40. Review.

PMID:
12351142
12.

The metabolism of tertiary amines.

Rose J, Castagnoli N Jr.

Med Res Rev. 1983 Jan-Mar;3(1):73-88. Review.

PMID:
6341732
13.

In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises.

Miners JO, Knights KM, Houston JB, Mackenzie PI.

Biochem Pharmacol. 2006 May 28;71(11):1531-9. Epub 2006 Feb 7. Review.

PMID:
16455060
14.

Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfation.

Burchell B, Coughtrie MW.

Environ Health Perspect. 1997 Jun;105 Suppl 4:739-47. Review.

15.

Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.

Singh SS.

Curr Drug Metab. 2006 Feb;7(2):165-82. Review.

PMID:
16472106
16.

Glucuronidation: a dual control.

Guéraud F, Paris A.

Gen Pharmacol. 1998 Nov;31(5):683-8. Review.

PMID:
9809463
17.

Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review.

Barbero AM, Frasch HF.

Toxicol In Vitro. 2009 Feb;23(1):1-13. doi: 10.1016/j.tiv.2008.10.008. Epub 2008 Oct 26. Review.

PMID:
19013230
18.

New developments in glucuronidation research: report of a workshop on "glucuronidation, its role in health and disease".

Jansen PL, Mulder GJ, Burchell B, Bock KW.

Hepatology. 1992 Mar;15(3):532-44. Review. No abstract available.

PMID:
1531971
19.
20.

Characterization of Species Differences in Xenobiotic Metabolism in Non-experimental Animals.

Mizukawa H, Ikenaka Y, Kakehi M, Nakayama S, Ishizuka M.

Yakugaku Zasshi. 2017;137(3):257-263. doi: 10.1248/yakushi.16-00230-2. Review. Japanese.

Supplemental Content

Support Center